GENTAMICIN

GENTAMICIN was reported 15943 times

GENTAMICIN is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 NORMAL LABOUR 96 0.6857
1 NEONATAL CANDIDA INFECTION 12 0.2791
2 BARTTER'S SYNDROME 10 0.2632
3 HAEMATOPOIETIC STEM CELL MOBILISATION 15 0.2344
4 ENDOCARDITIS CANDIDA 13 0.1711
5 POLYGLANDULAR DISORDER 11 0.1618
6 DELIVERY 103 0.1563
7 DELUSION OF GRANDEUR 61 0.1359
8 PERSISTENT GENITAL AROUSAL DISORDER 22 0.0948
9 AMINOACIDURIA 14 0.0881
10 OROPHARYNGEAL OEDEMA 12 0.0828
11 SPINAL MUSCULAR ATROPHY 21 0.0778
12 ANTIMICROBIAL SUSCEPTIBILITY TEST RESISTANT 21 0.0680
13 OSCILLOPSIA 16 0.0618
14 INTRAVENTRICULAR HAEMORRHAGE NEONATAL 30 0.0617
15 ANTIBIOTIC LEVEL ABOVE THERAPEUTIC 25 0.0616
16 VESTIBULAR DISORDER 73 0.0596
17 PROCEDURAL HYPERTENSION 11 0.0585
18 ANAEMIA FOLATE DEFICIENCY 11 0.0570
19 GEOTRICHUM INFECTION 12 0.0569
20 ENCEPHALITIS BRAIN STEM 9 0.0520
21 OTOTOXICITY 96 0.0519
22 CARDIAC VALVE VEGETATION 24 0.0494
23 POSITIVE AIRWAY PRESSURE THERAPY 13 0.0445
24 LYMPHOCYTE COUNT ABNORMAL 49 0.0435
25 NECROTISING ENTEROCOLITIS NEONATAL 17 0.0419
26 STOMA CLOSURE 13 0.0418
27 NONINFECTIOUS PERITONITIS 10 0.0412
28 ABDOMINAL COMPARTMENT SYNDROME 26 0.0408
29 RESPIRATORY TRACT INFECTION BACTERIAL 20 0.0402
30 HERPES ZOSTER REACTIVATION 10 0.0382
31 BACILLUS INFECTION 24 0.0380
32 CHRONIC KIDNEY DISEASE-MINERAL AND BONE DISORDER 39 0.0367
33 PNEUMOCOCCAL SEPSIS 24 0.0365
34 ENDOCARDITIS BACTERIAL 27 0.0343
35 HYPOPROTHROMBINAEMIA 10 0.0332
36 FUNGAL ENDOCARDITIS 10 0.0332
37 MOTOR NEURONE DISEASE 16 0.0329
38 SEPSIS SYNDROME 16 0.0319
39 CNS VENTRICULITIS 10 0.0307
40 ANISOCYTOSIS 20 0.0304
41 PYROGLUTAMIC ACIDOSIS 12 0.0302
42 HYPERPARATHYROIDISM SECONDARY 73 0.0291
43 NECROTISING COLITIS 36 0.0284
44 EPIDERMOLYSIS 13 0.0283
45 CRYSTALLURIA 15 0.0276
46 COAGULATION FACTOR V LEVEL DECREASED 9 0.0275
47 LISTERIOSIS 30 0.0271
48 NEONATAL TACHYPNOEA 11 0.0266
49 LINEAR IGA DISEASE 44 0.0264
50 SCROTAL PAIN 14 0.0259
51 MYOPERICARDITIS 20 0.0256
52 LOWER RESPIRATORY TRACT INFECTION BACTERIAL 13 0.0254
53 DISSEMINATED MUCORMYCOSIS 10 0.0254
54 SEPSIS NEONATAL 20 0.0246
55 ACINETOBACTER INFECTION 26 0.0237
56 NEPHROGENIC ANAEMIA 106 0.0229
57 INFECTIVE ANEURYSM 11 0.0222
58 RENAL TUBULAR NECROSIS 213 0.0217
59 SEPTIC EMBOLUS 18 0.0216
60 SERRATIA INFECTION 16 0.0215
61 NEONATAL DISORDER 34 0.0215
62 MYCOBACTERIUM ABSCESSUS INFECTION 15 0.0210
63 ASPERGILLOSIS 27 0.0207
64 ENDOCARDITIS 106 0.0206
65 METABOLIC ALKALOSIS 32 0.0199
66 NEONATAL RESPIRATORY FAILURE 10 0.0198
67 DEAFNESS NEUROSENSORY 65 0.0197
68 EXCESSIVE EYE BLINKING 29 0.0196
69 ABSCESS NECK 13 0.0192
70 PATHOGEN RESISTANCE 173 0.0190
71 RHINALGIA 52 0.0189
72 DRUG RASH WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS 61 0.0188
73 NUTRITIONAL CONDITION ABNORMAL 13 0.0186
74 KLEBSIELLA TEST POSITIVE 12 0.0184
75 GRUNTING 11 0.0184
76 NEPHRITIS INTERSTITIAL 23 0.0182
77 AMNIOTIC CAVITY INFECTION 13 0.0180
78 BACTERIAL DISEASE CARRIER 13 0.0178
79 ENTEROCOCCAL SEPSIS 14 0.0173
80 SYMMETRICAL DRUG-RELATED INTERTRIGINOUS AND FLEXURAL EXANTHEMA 14 0.0170
81 BRADYCARDIA NEONATAL 21 0.0167
82 FOLATE DEFICIENCY 19 0.0164
83 ISCHAEMIC CEREBRAL INFARCTION 19 0.0164
84 SKIN TEST POSITIVE 15 0.0161
85 ENTEROCOCCAL BACTERAEMIA 17 0.0160
86 PREMATURE DELIVERY 253 0.0159
87 HYPOPARATHYROIDISM 12 0.0156
88 CHRONIC HEPATITIS 12 0.0148
89 NEPHROPATHY TOXIC 166 0.0148
90 MACROCYTOSIS 17 0.0147
91 FUNGAEMIA 23 0.0146
92 PERINEAL PAIN 10 0.0140
93 URINARY TRACT INFECTION ENTEROCOCCAL 13 0.0139
94 NEONATAL RESPIRATORY DISTRESS 13 0.0138
95 HYPOPERFUSION 14 0.0133
96 RESUSCITATION 22 0.0133
97 METHAEMOGLOBINAEMIA 30 0.0129
98 LIVER ABSCESS 42 0.0129
99 DEATH NEONATAL 18 0.0129
100 SYSTEMIC MYCOSIS 15 0.0128
101 SYSTEMIC INFECTION 21 0.0127
102 STAPHYLOCOCCAL SEPSIS 62 0.0125
103 FUNGAL PERITONITIS 19 0.0125
104 NEONATAL RESPIRATORY DISTRESS SYNDROME 44 0.0124
105 ENTEROCOCCAL INFECTION 60 0.0124
106 PARAPARESIS 22 0.0123
107 LYMPHADENECTOMY 12 0.0123
108 LUNG CONSOLIDATION 34 0.0121
109 CORNEAL DEPOSITS 9 0.0121
110 HYPOPYON 10 0.0121
111 PREMATURE BABY 348 0.0115
112 SPUTUM INCREASED 25 0.0115
113 CLOSTRIDIUM COLITIS 14 0.0115
114 END STAGE RENAL DISEASE 210 0.0115
115 TOXIC EPIDERMAL NECROLYSIS 173 0.0114
116 NEUTROPENIC SEPSIS 81 0.0113
117 ENTEROBACTER INFECTION 19 0.0113
118 PYURIA 11 0.0111
119 BRONCHIAL DISORDER 17 0.0109
120 LYMPHOCYTIC INFILTRATION 11 0.0109
121 DISTURBANCE IN SEXUAL AROUSAL 10 0.0109
122 ACUTE GENERALISED EXANTHEMATOUS PUSTULOSIS 84 0.0108
123 OLIGURIA 67 0.0108
124 DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS 276 0.0107
125 COAGULATION TIME PROLONGED 16 0.0103
126 KLEBSIELLA INFECTION 51 0.0101
127 BLOOD CULTURE POSITIVE 30 0.0100
128 SKIN OEDEMA 10 0.0100
129 EOSINOPHILIA 175 0.0100
130 SYSTEMIC CANDIDA 25 0.0099
131 MULTI-ORGAN FAILURE 169 0.0098
132 LOW BIRTH WEIGHT BABY 76 0.0096
133 URETEROLITHIASIS 10 0.0095
134 INCREASED BRONCHIAL SECRETION 24 0.0094
135 PROCALCITONIN INCREASED 11 0.0094
136 RASH MORBILLIFORM 26 0.0094
137 ENDOCRINE DISORDER 12 0.0094
138 NEPHROCALCINOSIS 11 0.0093
139 RENAL TUBULAR DISORDER 26 0.0092
140 MUCORMYCOSIS 24 0.0092
141 RESPIRATORY ALKALOSIS 15 0.0092
142 AORTIC VALVE INCOMPETENCE 39 0.0092
143 CHEST X-RAY ABNORMAL 28 0.0091
144 STAPHYLOCOCCAL BACTERAEMIA 39 0.0090
145 PSEUDOMEMBRANOUS COLITIS 20 0.0089
146 REBOUND ACID HYPERSECRETION 27 0.0089
147 GASTROINTESTINAL BACTERIAL INFECTION 10 0.0087
148 CARDIAC VENTRICULAR THROMBOSIS 11 0.0085
149 RENAL FAILURE ACUTE 359 0.0085
150 CYTOLYTIC HEPATITIS 28 0.0084
151 FOOT AMPUTATION 12 0.0082
152 DEAFNESS BILATERAL 14 0.0082
153 PERITONITIS BACTERIAL 83 0.0082
154 INHIBITORY DRUG INTERACTION 13 0.0082
155 VASCULAR DEVICE INFECTION 37 0.0081
156 AORTIC VALVE DISEASE 13 0.0081
157 AFFECTIVE DISORDER 63 0.0080
158 HAEMODYNAMIC INSTABILITY 61 0.0080
159 INTERVERTEBRAL DISCITIS 15 0.0079
160 BRAIN ABSCESS 20 0.0079
161 MULTIPLE-DRUG RESISTANCE 24 0.0077
162 INTRAVENTRICULAR HAEMORRHAGE 19 0.0076
163 TUBULOINTERSTITIAL NEPHRITIS 142 0.0076
164 MULTIPLE ORGAN DYSFUNCTION SYNDROME 214 0.0075
165 SEPTIC SHOCK 326 0.0075
166 PSEUDOMONAL SEPSIS 13 0.0074
167 STENOTROPHOMONAS INFECTION 10 0.0074
168 MECHANICAL VENTILATION 14 0.0074
169 ESCHERICHIA INFECTION 60 0.0073
170 POLYCYTHAEMIA 15 0.0073
171 NEUTROPHIL COUNT INCREASED 73 0.0071
172 DRUG RESISTANCE 183 0.0071
173 PNEUMONIA KLEBSIELLA 13 0.0071
174 TOXIC SKIN ERUPTION 71 0.0070
175 LYMPHOCYTOSIS 15 0.0070
176 HYPOTHALAMO-PITUITARY DISORDER 10 0.0069
177 HYPERSENSITIVITY VASCULITIS 18 0.0068
178 POTENTIATING DRUG INTERACTION 23 0.0068
179 CANDIDA INFECTION 115 0.0068
180 NECROTISING FASCIITIS 24 0.0068
181 DIVERTICULAR PERFORATION 14 0.0068
182 CLOSTRIDIAL INFECTION 23 0.0068
183 ACUTE KIDNEY INJURY 1040 0.0068
184 HAEMODIALYSIS 57 0.0068
185 ENDOTRACHEAL INTUBATION 19 0.0068
186 GENITAL PAIN 10 0.0068
187 PSEUDOMONAS INFECTION 58 0.0068
188 ANURIA 58 0.0067
189 MUCOSAL INFLAMMATION 174 0.0066
190 CEREBRAL ISCHAEMIA 34 0.0066
191 PATENT DUCTUS ARTERIOSUS 26 0.0065
192 INTESTINAL ISCHAEMIA 36 0.0065
193 RETROPERITONEAL HAEMORRHAGE 16 0.0065
194 FIXED ERUPTION 11 0.0064
195 ANTICONVULSANT DRUG LEVEL DECREASED 9 0.0064
196 NOSOCOMIAL INFECTION 14 0.0063
197 HUMAN HERPESVIRUS 6 INFECTION 12 0.0063
198 ELECTROCARDIOGRAM T WAVE INVERSION 14 0.0063
199 RASH MACULO-PAPULAR 139 0.0062
200 TYPE IV HYPERSENSITIVITY REACTION 17 0.0062
201 STAPHYLOCOCCUS TEST POSITIVE 13 0.0062
202 APNOEA 48 0.0062
203 INFLAMMATORY MARKER INCREASED 30 0.0060
204 NEPHRITIS 20 0.0060
205 WOUND DEHISCENCE 20 0.0059
206 CLOSTRIDIUM TEST POSITIVE 13 0.0059
207 PULMONARY HAEMORRHAGE 46 0.0059
208 PERITONITIS 121 0.0058
209 CORNEAL OEDEMA 13 0.0058
210 TONGUE COATED 10 0.0058
211 STRIDOR 17 0.0058
212 DISEASE COMPLICATION 26 0.0057
213 ASPERGILLUS INFECTION 37 0.0056
214 ARTHRITIS BACTERIAL 23 0.0056
215 APPLICATION SITE SCAB 12 0.0056
216 BACTERIAL SEPSIS 18 0.0055
217 VENOOCCLUSIVE LIVER DISEASE 27 0.0055
218 HYPERNATRAEMIA 27 0.0054
219 OPPORTUNISTIC INFECTION 10 0.0054
220 HISTIOCYTOSIS HAEMATOPHAGIC 16 0.0054
221 PLASMACYTOMA 10 0.0054
222 THYROIDITIS 16 0.0053
223 CAPILLARY LEAK SYNDROME 11 0.0053
224 AKINESIA 11 0.0053
225 GLOMERULONEPHRITIS 13 0.0053
226 CHRONIC KIDNEY DISEASE 403 0.0053
227 ATRIOVENTRICULAR BLOCK SECOND DEGREE 16 0.0053
228 BLOOD AMYLASE INCREASED 9 0.0053
229 NECROSIS 29 0.0052
230 SCHIZOPHRENIA 63 0.0052
231 HAEMOLYTIC URAEMIC SYNDROME 12 0.0052
232 DEMYELINATION 21 0.0051
233 JAUNDICE CHOLESTATIC 18 0.0051
234 EMPYEMA 10 0.0050
235 CEREBELLAR SYNDROME 11 0.0050
236 RENAL INJURY 149 0.0050
237 METABOLIC ACIDOSIS 160 0.0050
238 DERMATITIS EXFOLIATIVE 25 0.0050
239 SYSTEMIC INFLAMMATORY RESPONSE SYNDROME 19 0.0050
240 LEUKOCYTOSIS 89 0.0049
241 CLOSTRIDIUM DIFFICILE COLITIS 52 0.0049
242 DERMATITIS EXFOLIATIVE GENERALISED 17 0.0049
243 ATRIAL THROMBOSIS 10 0.0048
244 LYMPHOCYTE COUNT DECREASED 85 0.0048
245 DILATATION VENTRICULAR 10 0.0048
246 HALLUCINATION, AUDITORY 75 0.0047
247 BACTERAEMIA 56 0.0047
248 ACUTE RESPIRATORY DISTRESS SYNDROME 83 0.0047
249 VITILIGO 11 0.0047
250 CHOLESTASIS 90 0.0047
251 BRAIN HERNIATION 14 0.0047
252 CLOSTRIDIUM DIFFICILE INFECTION 102 0.0047
253 RENAL FAILURE 619 0.0047
254 ATELECTASIS 45 0.0047
255 CUTANEOUS VASCULITIS 17 0.0047
256 PURPURA 41 0.0046
257 DRUG LEVEL INCREASED 76 0.0046
258 DISSEMINATED INTRAVASCULAR COAGULATION 64 0.0045
259 OTITIS MEDIA 15 0.0045
260 CANDIDIASIS 18 0.0045
261 COMA SCALE ABNORMAL 13 0.0045
262 DEVICE RELATED SEPSIS 9 0.0045
263 FEBRILE BONE MARROW APLASIA 19 0.0045
264 ESCHERICHIA URINARY TRACT INFECTION 19 0.0045
265 FOETAL EXPOSURE DURING PREGNANCY 362 0.0044
266 LUNG INFILTRATION 39 0.0044
267 PETECHIAE 46 0.0044
268 ACTIVATED PARTIAL THROMBOPLASTIN TIME PROLONGED 22 0.0043
269 HYPERBILIRUBINAEMIA 45 0.0043
270 HEPATOSPLENOMEGALY 11 0.0043
271 DERMATITIS BULLOUS 31 0.0043
272 KERATITIS 13 0.0043
273 DYSAESTHESIA 13 0.0042
274 MITRAL VALVE INCOMPETENCE 48 0.0042
275 IMMUNE RECONSTITUTION INFLAMMATORY SYNDROME 21 0.0042
276 THERAPEUTIC AGENT TOXICITY 14 0.0042
277 EXFOLIATIVE RASH 11 0.0042
278 RESPIRATORY DISTRESS 115 0.0042
279 GUILLAIN-BARRE SYNDROME 20 0.0041
280 METABOLIC DISORDER 24 0.0041
281 ARTHRITIS INFECTIVE 19 0.0041
282 ACUTE PSYCHOSIS 10 0.0040
283 ODYNOPHAGIA 24 0.0040
284 ULCERATIVE KERATITIS 11 0.0040
285 VENTRICULAR HYPERTROPHY 10 0.0040
286 BONE MARROW DISORDER 12 0.0040
287 SARS-COV-2 TEST POSITIVE 52 0.0039
288 SEPSIS 439 0.0039
289 SHOCK HAEMORRHAGIC 32 0.0039
290 DRUG LEVEL ABOVE THERAPEUTIC 18 0.0039
291 STEVENS-JOHNSON SYNDROME 86 0.0039
292 VENTRICULAR DYSFUNCTION 10 0.0039
293 HYDROCEPHALUS 21 0.0039
294 BILIRUBIN CONJUGATED INCREASED 9 0.0038
295 GINGIVAL SWELLING 17 0.0038
296 DEVICE RELATED INFECTION 59 0.0038
297 CIRCULATORY COLLAPSE 65 0.0038
298 EOSINOPHILIC PNEUMONIA 12 0.0038
299 ADENOVIRUS INFECTION 11 0.0038
300 HYPOVOLAEMIA 22 0.0038
301 BLOOD CREATININE ABNORMAL 13 0.0038
302 MATERNAL EXPOSURE DURING PREGNANCY 335 0.0038
303 AZOTAEMIA 15 0.0038
304 TACHYPNOEA 51 0.0037
305 BRONCHOPULMONARY ASPERGILLOSIS 29 0.0037
306 HYPERLACTACIDAEMIA 10 0.0037
307 ENDOPHTHALMITIS 22 0.0037
308 SKIN NECROSIS 19 0.0037
309 RENAL FAILURE CHRONIC 28 0.0036
310 NEPHROGENIC SYSTEMIC FIBROSIS 11 0.0036
311 STATUS EPILEPTICUS 41 0.0036
312 CATHETER SITE HAEMORRHAGE 9 0.0036
313 DRUG ERUPTION 63 0.0036
314 AGRANULOCYTOSIS 66 0.0035
315 HEPATITIS ACUTE 23 0.0035
316 HYPERTHERMIA 27 0.0035
317 RENAL IMPAIRMENT 297 0.0035
318 SHOCK 81 0.0035
319 STILLBIRTH 17 0.0035
320 NEUTROPHILIA 20 0.0035
321 PROTHROMBIN TIME PROLONGED 21 0.0035
322 HEPATITIS CHOLESTATIC 21 0.0035
323 ISCHAEMIA 16 0.0035
324 FOETAL DEATH 18 0.0035
325 ENCEPHALOPATHY 85 0.0035
326 HAEMOLYTIC ANAEMIA 31 0.0035
327 STAPHYLOCOCCAL INFECTION 114 0.0035
328 PROTEIN TOTAL DECREASED 13 0.0034
329 CATHETER SITE INFECTION 13 0.0034
330 MOTOR DYSFUNCTION 35 0.0034
331 PERITONEAL DIALYSIS COMPLICATION 25 0.0034
332 STUPOR 11 0.0034
333 STREPTOCOCCAL INFECTION 19 0.0034
334 COLITIS ISCHAEMIC 23 0.0034
335 ANAPHYLACTIC REACTION 187 0.0034
336 ANGIONEUROTIC OEDEMA 9 0.0034
337 COAGULOPATHY 56 0.0034
338 TOXIC ENCEPHALOPATHY 17 0.0034
339 HEPATOCELLULAR INJURY 47 0.0033
340 RESPIRATORY ACIDOSIS 13 0.0033
341 HYPERPYREXIA 14 0.0033
342 BLOOD UREA INCREASED 55 0.0033
343 THROMBOCYTOSIS 12 0.0033
344 EXTRAPYRAMIDAL DISORDER 81 0.0033
345 DUODENITIS 10 0.0033
346 UROSEPSIS 30 0.0032
347 CREATININE RENAL CLEARANCE DECREASED 13 0.0032
348 ATRIOVENTRICULAR BLOCK FIRST DEGREE 14 0.0032
349 SCOLIOSIS 20 0.0032
350 HYPERCHLORHYDRIA 19 0.0032
351 BLOOD ALKALINE PHOSPHATASE INCREASED 80 0.0032
352 BRONCHOPNEUMONIA 11 0.0032
353 HYPERKALAEMIA 112 0.0032
354 EXTRAVASATION 13 0.0032
355 EJECTION FRACTION DECREASED 49 0.0031
356 BLOOD CREATININE INCREASED 205 0.0031
357 HYPOTONIA 31 0.0031
358 BRAIN INJURY 31 0.0031
359 CONJUNCTIVAL HYPERAEMIA 11 0.0031
360 HYDRONEPHROSIS 23 0.0031
361 HYPOCALCAEMIA 58 0.0031
362 PANCYTOPENIA 171 0.0031
363 BLOOD ALBUMIN DECREASED 24 0.0030
364 CREPITATIONS 9 0.0030
365 ABDOMINAL TENDERNESS 15 0.0030
366 DRUG TOXICITY 41 0.0030
367 CHOLECYSTITIS ACUTE 17 0.0030
368 LEUKOPENIA 150 0.0030
369 CEREBROVASCULAR DISORDER 9 0.0030
370 WOUND HAEMORRHAGE 11 0.0030
371 URINE OUTPUT DECREASED 26 0.0030
372 SKIN LESION 81 0.0029
373 PSYCHOTIC DISORDER 87 0.0029
374 ABDOMINAL ABSCESS 13 0.0029
375 PERIPHERAL ISCHAEMIA 12 0.0029
376 MYOCLONUS 35 0.0029
377 GRAFT VERSUS HOST DISEASE 21 0.0029
378 C-REACTIVE PROTEIN INCREASED 106 0.0029
379 GENERALISED OEDEMA 36 0.0029
380 CHOLANGITIS 18 0.0029
381 MYOSITIS 26 0.0029
382 CELLULITIS 146 0.0029
383 BACTERIAL INFECTION 54 0.0029
384 ANHEDONIA 76 0.0029
385 NEPHROPATHY 27 0.0029
386 DIALYSIS 41 0.0029
387 THROMBOCYTOPENIA 322 0.0029
388 ACIDOSIS 22 0.0029
389 PULSELESS ELECTRICAL ACTIVITY 12 0.0029
390 SKIN INFECTION 32 0.0028
391 INTESTINAL PERFORATION 32 0.0028
392 FACE OEDEMA 48 0.0028
393 HEPARIN-INDUCED THROMBOCYTOPENIA 14 0.0028
394 HYPOPHOSPHATAEMIA 21 0.0028
395 VASCULITIS 33 0.0028
396 HEPATITIS 72 0.0028
397 HYPOXIA 99 0.0028
398 PURULENT DISCHARGE 12 0.0028
399 BODY TEMPERATURE INCREASED 57 0.0028
400 PYELONEPHRITIS 24 0.0028
401 CYTOMEGALOVIRUS INFECTION 46 0.0028
402 LYMPHOEDEMA 19 0.0027
403 PETIT MAL EPILEPSY 14 0.0027
404 NEUROTOXICITY 48 0.0027
405 HYPOKALAEMIA 126 0.0027
406 FUNGAL SKIN INFECTION 11 0.0027
407 BLOOD CREATINE INCREASED 12 0.0027
408 HYPOALBUMINAEMIA 21 0.0027
409 SINUS BRADYCARDIA 26 0.0027
410 ILEUS PARALYTIC 12 0.0027
411 MALNUTRITION 30 0.0027
412 FEAR 72 0.0027
413 TRICUSPID VALVE INCOMPETENCE 21 0.0026
414 DIFFICULTY IN WALKING 9 0.0026
415 PULMONARY HYPERTENSION 54 0.0026
416 PATHOLOGICAL FRACTURE 13 0.0026
417 WOUND INFECTION 28 0.0026
418 FLUID OVERLOAD 37 0.0025
419 PNEUMONIA FUNGAL 10 0.0025
420 FEBRILE NEUTROPENIA 168 0.0025
421 IMMUNE EFFECTOR CELL-ASSOCIATED NEUROTOXICITY SYNDROME 15 0.0025
422 EOSINOPHIL COUNT INCREASED 21 0.0025
423 INTRACRANIAL PRESSURE INCREASED 14 0.0025
424 DRUG ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE 18 0.0025
425 EXPOSURE VIA BREAST MILK 10 0.0025
426 CAESAREAN SECTION 29 0.0025
427 DRUG INTERACTION 391 0.0025
428 CARDIAC VALVE DISEASE 14 0.0024
429 LARGE INTESTINE PERFORATION 17 0.0024
430 ACUTE RESPIRATORY FAILURE 47 0.0024
431 CARDIOGENIC SHOCK 35 0.0024
432 COMPRESSION FRACTURE 13 0.0024
433 HAEMATURIA 83 0.0024
434 GASTROINTESTINAL SOUNDS ABNORMAL 12 0.0024
435 RESPIRATORY FAILURE 175 0.0024
436 HAEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS 18 0.0024
437 MENINGITIS 16 0.0024
438 ASCITES 70 0.0024
439 BLOOD BILIRUBIN INCREASED 64 0.0024
440 NEUTROPENIA 322 0.0024
441 RASH ERYTHEMATOUS 113 0.0024
442 DYSLIPIDAEMIA 12 0.0024
443 DRUG LEVEL BELOW THERAPEUTIC 13 0.0024
444 MATERNAL DRUGS AFFECTING FOETUS 18 0.0023
445 TRANSAMINASES INCREASED 52 0.0023
446 PNEUMOTHORAX 37 0.0023
447 HAEMOLYSIS 18 0.0023
448 JOINT EFFUSION 16 0.0023
449 CONJUNCTIVITIS 43 0.0023
450 ACUTE PULMONARY OEDEMA 13 0.0023
451 ECONOMIC PROBLEM 35 0.0023
452 RHABDOMYOLYSIS 96 0.0023
453 PREMATURE LABOUR 13 0.0023
454 EMBOLISM 19 0.0023
455 NASAL DISCOMFORT 18 0.0023
456 LIVER FUNCTION TEST ABNORMAL 66 0.0023
457 BONE MARROW FAILURE 46 0.0023
458 NYSTAGMUS 12 0.0023
459 CEREBRAL ATROPHY 9 0.0023
460 ENTEROCOLITIS 13 0.0022
461 ERYTHEMA MULTIFORME 21 0.0022
462 LEFT VENTRICULAR DYSFUNCTION 15 0.0022
463 HEPATOMEGALY 22 0.0022
464 SKIN WARM 13 0.0022
465 PYREXIA 771 0.0022
466 LIPASE INCREASED 17 0.0022
467 HEPATIC CYTOLYSIS 28 0.0022
468 CARDIOMEGALY 27 0.0022
469 FOLLICULITIS 23 0.0022
470 PNEUMONIA ASPIRATION 54 0.0022
471 GANGRENE 13 0.0022
472 PULMONARY ALVEOLAR HAEMORRHAGE 12 0.0021
473 FAILURE TO THRIVE 11 0.0021
474 ABSCESS LIMB 9 0.0021
475 TROPONIN INCREASED 16 0.0021
476 OSTEOMYELITIS 38 0.0021
477 HYPOTENSION 420 0.0021
478 HEPATIC FAILURE 63 0.0021
479 HYPOVOLAEMIC SHOCK 10 0.0021
480 TACHYCARDIA 185 0.0021
481 LIVER INJURY 51 0.0021
482 GAMMA-GLUTAMYLTRANSFERASE INCREASED 46 0.0021
483 ATRIOVENTRICULAR BLOCK 16 0.0021
484 BRAIN OEDEMA 26 0.0021
485 GASTROENTERITIS 30 0.0021
486 ANAPHYLACTIC SHOCK 53 0.0021
487 MUSCLE ATROPHY 26 0.0021
488 ORAL CANDIDIASIS 27 0.0020
489 ELECTROCARDIOGRAM ABNORMAL 16 0.0020
490 WHITE BLOOD CELL COUNT INCREASED 78 0.0020
491 C-REACTIVE PROTEIN ABNORMAL 13 0.0020
492 ENCEPHALITIS 14 0.0020
493 HYPOMAGNESAEMIA 28 0.0020
494 DEAFNESS UNILATERAL 11 0.0020
495 BLISTER 112 0.0020
496 TENDON DISORDER 13 0.0020
497 INCONTINENCE 21 0.0020
498 RETINAL HAEMORRHAGE 14 0.0020
499 INJURY 138 0.0020
500 BRONCHOSPASM 28 0.0020
501 PANCREATITIS ACUTE 44 0.0020
502 PHLEBITIS 10 0.0020
503 FEMORAL NECK FRACTURE 10 0.0019
504 FUNGAL INFECTION 65 0.0019
505 CYTOKINE RELEASE SYNDROME 39 0.0019
506 RASH PUSTULAR 14 0.0019
507 ATRIAL SEPTAL DEFECT 16 0.0019
508 BLOOD POTASSIUM INCREASED 31 0.0019
509 INFUSION SITE SWELLING 12 0.0019
510 ACUTE HEPATIC FAILURE 26 0.0019
511 INTERNATIONAL NORMALISED RATIO INCREASED 54 0.0019
512 ELECTROLYTE IMBALANCE 22 0.0019
513 PROTEINURIA 36 0.0019
514 HAEMATOMA 49 0.0019
515 FEELING OF BODY TEMPERATURE CHANGE 11 0.0019
516 DELIRIUM 65 0.0019
517 FISTULA 21 0.0019
518 UNRESPONSIVE TO STIMULI 48 0.0019
519 BREATH SOUNDS ABNORMAL 9 0.0018
520 DISEASE PROGRESSION 215 0.0018
521 VENTRICULAR TACHYCARDIA 30 0.0018
522 EYELID OEDEMA 21 0.0018
523 MOUTH ULCERATION 38 0.0018
524 CARDIAC FAILURE ACUTE 12 0.0018
525 SUPRAVENTRICULAR TACHYCARDIA 17 0.0018
526 MELAENA 39 0.0018
527 LYMPHOPENIA 25 0.0018
528 PULMONARY OEDEMA 79 0.0018
529 DEAFNESS 46 0.0018
530 ALANINE AMINOTRANSFERASE INCREASED 108 0.0018
531 SECRETION DISCHARGE 22 0.0018
532 ATRIAL FLUTTER 14 0.0018
533 BLOOD DISORDER 14 0.0017
534 JAUNDICE 47 0.0017
535 HYPERTONIA 10 0.0017
536 PNEUMONIA BACTERIAL 16 0.0017
537 RESPIRATORY ARREST 48 0.0017
538 HYPONATRAEMIA 98 0.0017
539 CARDIAC ARREST 143 0.0017
540 TREATMENT FAILURE 143 0.0017
541 APLASTIC ANAEMIA 9 0.0017
542 HEPATOTOXICITY 38 0.0017
543 APPLICATION SITE VESICLES 11 0.0017
544 MUSCLE INJURY 14 0.0017
545 RESPIRATORY RATE INCREASED 15 0.0017
546 DERMATITIS 35 0.0017
547 DRUG LEVEL DECREASED 17 0.0017
548 NEUTROPHIL COUNT DECREASED 68 0.0017
549 VISUAL FIELD DEFECT 12 0.0017
550 BRADYCARDIA 88 0.0017
551 TORSADE DE POINTES 13 0.0017
552 OXYGEN SATURATION DECREASED 93 0.0017
553 PLATELET COUNT ABNORMAL 10 0.0017
554 ADRENAL INSUFFICIENCY 20 0.0016
555 ABSCESS 26 0.0016
556 SMALL INTESTINAL OBSTRUCTION 20 0.0016
557 SPLENOMEGALY 19 0.0016
558 MENTAL STATUS CHANGES 45 0.0016
559 CARDIAC MURMUR 14 0.0016
560 ANAEMIA 308 0.0016
561 FLANK PAIN 15 0.0016
562 ASPARTATE AMINOTRANSFERASE INCREASED 85 0.0016
563 DECUBITUS ULCER 13 0.0016
564 COLITIS 60 0.0016
565 HYPOTHERMIA 16 0.0016
566 WHITE BLOOD CELL COUNT ABNORMAL 10 0.0016
567 PAPULE 11 0.0016
568 EXPOSURE DURING PREGNANCY 97 0.0016
569 THERAPY NON-RESPONDER 70 0.0016
570 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 84 0.0015
571 BLOOD CREATINE PHOSPHOKINASE INCREASED 44 0.0015
572 SEIZURE 176 0.0015
573 PLATELET COUNT DECREASED 161 0.0015
574 ORAL HERPES 29 0.0015
575 LACTIC ACIDOSIS 48 0.0015
576 SINUS TACHYCARDIA 21 0.0015
577 LETHARGY 85 0.0015
578 NO THERAPEUTIC RESPONSE 18 0.0015
579 HAEMORRHAGE INTRACRANIAL 22 0.0015
580 POLYURIA 12 0.0015
581 ECCHYMOSIS 10 0.0015
582 HYPERTRANSAMINASAEMIA 10 0.0014
583 PNEUMONITIS 39 0.0014
584 DERMATITIS ALLERGIC 18 0.0014
585 CONDITION AGGRAVATED 435 0.0014
586 RASH MACULAR 50 0.0014
587 RASH GENERALISED 37 0.0014
588 PERICARDIAL EFFUSION 33 0.0014
589 GASTROOESOPHAGEAL REFLUX DISEASE 114 0.0014
590 NEOPLASM PROGRESSION 49 0.0014
591 NEUROPATHY PERIPHERAL 134 0.0014
592 MYOCARDIAL ISCHAEMIA 16 0.0014
593 PARANOIA 24 0.0014
594 PRODUCT USE IN UNAPPROVED INDICATION 343 0.0014
595 DRUG EXPOSURE DURING PREGNANCY 47 0.0014
596 ARTERIOSCLEROSIS 13 0.0014
597 PLATELET COUNT INCREASED 18 0.0014
598 PLEURAL EFFUSION 84 0.0014
599 GROIN PAIN 12 0.0014
600 DYSGRAPHIA 9 0.0014
601 INAPPROPRIATE ANTIDIURETIC HORMONE SECRETION 14 0.0014
602 LOWER RESPIRATORY TRACT INFECTION 61 0.0013
603 HAEMATEMESIS 34 0.0013
604 BLOOD LACTATE DEHYDROGENASE INCREASED 21 0.0013
605 JOINT DISLOCATION 14 0.0013
606 OSTEOPENIA 20 0.0013
607 HYPERGLYCAEMIA 48 0.0013
608 HEPATIC FUNCTION ABNORMAL 49 0.0013
609 BALANCE DISORDER 113 0.0013
610 PANCREATITIS 69 0.0013
611 SKIN PLAQUE 11 0.0013
612 POST PROCEDURAL COMPLICATION 25 0.0013
613 GRAND MAL CONVULSION 12 0.0013
614 HYPERCALCAEMIA 16 0.0013
615 PULMONARY EMBOLISM 123 0.0013
616 RASH PRURITIC 70 0.0013
617 URINARY RETENTION 43 0.0013
618 GASTROINTESTINAL HAEMORRHAGE 107 0.0013
619 ATAXIA 15 0.0013
620 INFLAMMATION 65 0.0013
621 UNEVALUABLE EVENT 95 0.0013
622 OEDEMA 68 0.0013
623 RASH PAPULAR 28 0.0012
624 TENDERNESS 13 0.0012
625 GENERAL PHYSICAL HEALTH DETERIORATION 144 0.0012
626 DISORIENTATION 49 0.0012
627 RESPIRATORY TRACT INFECTION 32 0.0012
628 SCAB 14 0.0012
629 VITREOUS FLOATERS 12 0.0012
630 TINNITUS 56 0.0012
631 LYMPHADENOPATHY 43 0.0012
632 HAEMATOCRIT DECREASED 24 0.0012
633 SKIN ULCER 31 0.0012
634 RETINAL DETACHMENT 11 0.0012
635 LIVE BIRTH 10 0.0012
636 HEART RATE IRREGULAR 27 0.0012
637 CYSTITIS 38 0.0012
638 QUALITY OF LIFE DECREASED 16 0.0012
639 SUBARACHNOID HAEMORRHAGE 12 0.0012
640 APPENDICITIS 11 0.0012
641 VENTRICULAR EXTRASYSTOLES 12 0.0012
642 EYE INFLAMMATION 11 0.0012
643 CARDIOMYOPATHY 17 0.0011
644 HAEMOGLOBIN DECREASED 118 0.0011
645 DYSPEPSIA 113 0.0011
646 COORDINATION ABNORMAL 16 0.0011
647 CHILLS 134 0.0011
648 PALLOR 31 0.0011
649 IMMUNOSUPPRESSION 10 0.0011
650 ATRIAL FIBRILLATION 110 0.0011
651 UPPER GASTROINTESTINAL HAEMORRHAGE 19 0.0011
652 APHASIA 34 0.0011
653 CARDIAC FAILURE 90 0.0011
654 JOINT RANGE OF MOTION DECREASED 15 0.0011
655 ANAL INCONTINENCE 10 0.0011
656 WOUND 31 0.0011
657 GASTRIC ULCER 21 0.0011
658 URINARY TRACT INFECTION 188 0.0011
659 GASTRITIS 29 0.0011
660 OESOPHAGITIS 12 0.0011
661 HYPOGLYCAEMIA 53 0.0011
662 PERIPHERAL COLDNESS 15 0.0011
663 ACUTE MYELOID LEUKAEMIA 17 0.0011
664 ANOREXIA 14 0.0011
665 POLYNEUROPATHY 13 0.0011
666 HEPATIC ENCEPHALOPATHY 10 0.0011
667 KIDNEY INFECTION 21 0.0011
668 CHOLELITHIASIS 35 0.0011
669 EYE INFECTION 12 0.0011
670 PNEUMONIA 344 0.0011
671 PAIN IN JAW 30 0.0011
672 ELECTROCARDIOGRAM QT PROLONGED 38 0.0011
673 VISUAL ACUITY REDUCED 35 0.0011
674 SCAR 18 0.0011
675 ILEUS 13 0.0010
676 PELVIC PAIN 19 0.0010
677 TOXICITY TO VARIOUS AGENTS 175 0.0010
678 NERVOUS SYSTEM DISORDER 32 0.0010
679 NIGHT SWEATS 33 0.0010
680 SEXUAL DYSFUNCTION 12 0.0010
681 DEEP VEIN THROMBOSIS 66 0.0010
682 ALTERED STATE OF CONSCIOUSNESS 22 0.0010
683 INTERSTITIAL LUNG DISEASE 49 0.0010
684 DEPRESSED LEVEL OF CONSCIOUSNESS 40 0.0010
685 BLOOD PRESSURE DECREASED 67 0.0010
686 EMOTIONAL DISTRESS 122 0.0010
687 CARDIO-RESPIRATORY ARREST 42 0.0010
688 MASS 14 0.0010
689 HALLUCINATION, VISUAL 21 0.0010
690 VENTRICULAR FIBRILLATION 11 0.0010
691 SEROTONIN SYNDROME 19 0.0010
692 RESPIRATORY DEPRESSION 12 0.0010
693 RESPIRATORY DISORDER 29 0.0010
694 HEPATIC STEATOSIS 18 0.0010
695 DEFORMITY 9 0.0010
696 CONVULSION 55 0.0010
697 DRUG-INDUCED LIVER INJURY 30 0.0010
698 ACUTE MYOCARDIAL INFARCTION 28 0.0009
699 SCRATCH 10 0.0009
700 CONFUSIONAL STATE 152 0.0009
701 PULMONARY FIBROSIS 18 0.0009
702 DEHYDRATION 125 0.0009
703 SENSORY DISTURBANCE 15 0.0009
704 BONE DISORDER 17 0.0009
705 HAEMOPTYSIS 26 0.0009
706 LIP SWELLING 31 0.0009
707 OSTEONECROSIS OF JAW 23 0.0009
708 DIZZINESS POSTURAL 9 0.0009
709 DYSTONIA 18 0.0009
710 CHOLECYSTITIS 11 0.0009
711 VERTIGO 56 0.0009
712 ASPIRATION 10 0.0009
713 WHEEZING 54 0.0009
714 GENERALISED TONIC-CLONIC SEIZURE 15 0.0009
715 DYSPHAGIA 86 0.0009
716 CEREBRAL INFARCTION 22 0.0009
717 OEDEMA PERIPHERAL 109 0.0009
718 CEREBRAL HAEMORRHAGE 32 0.0009
719 SKIN EXFOLIATION 75 0.0009
720 REBOUND EFFECT 10 0.0009
721 DRUG WITHDRAWAL SYNDROME NEONATAL 13 0.0009
722 EAR DISCOMFORT 9 0.0009
723 DERMATITIS CONTACT 10 0.0009
724 SWOLLEN TONGUE 27 0.0009
725 MEDICATION ERROR 48 0.0009
726 DISEASE RECURRENCE 41 0.0009
727 ABDOMINAL PAIN 200 0.0009
728 BLOOD SODIUM DECREASED 16 0.0008
729 ARRHYTHMIA 40 0.0008
730 ISCHAEMIC STROKE 15 0.0008
731 COMA 40 0.0008
732 DRUG INEFFECTIVE 1107 0.0008
733 LUNG DISORDER 41 0.0008
734 INFECTION 121 0.0008
735 COGNITIVE DISORDER 39 0.0008
736 ABDOMINAL DISTENSION 87 0.0008
737 THERAPY PARTIAL RESPONDER 13 0.0008
738 SWELLING FACE 54 0.0008
739 PULMONARY ARTERIAL HYPERTENSION 12 0.0008
740 CYANOSIS 13 0.0008
741 OFF LABEL USE 719 0.0008
742 ACCIDENTAL OVERDOSE 30 0.0008
743 OBESITY 13 0.0008
744 RENAL DISORDER 38 0.0008
745 PULMONARY MASS 12 0.0008
746 BLOOD CALCIUM DECREASED 9 0.0008
747 BLOOD POTASSIUM DECREASED 24 0.0008
748 RECTAL HAEMORRHAGE 34 0.0008
749 ANGIOEDEMA 35 0.0008
750 HYPOACUSIS 34 0.0008
751 RASH 344 0.0008
752 EPISTAXIS 59 0.0008
753 CHEST PAIN 146 0.0008
754 MUSCLE TWITCHING 18 0.0008
755 ERYTHEMA 159 0.0008
756 LUNG INFECTION 12 0.0008
757 DIPLOPIA 20 0.0008
758 PARALYSIS 11 0.0008
759 NODULE 10 0.0008
760 ANXIETY 218 0.0008
761 MUSCULAR WEAKNESS 87 0.0008
762 BEDRIDDEN 10 0.0008
763 ACTIVITIES OF DAILY LIVING IMPAIRED 15 0.0008
764 AGITATION 55 0.0007
765 DIARRHOEA 483 0.0007
766 INTESTINAL OBSTRUCTION 28 0.0007
767 FOOT FRACTURE 14 0.0007
768 DYSURIA 27 0.0007
769 CONTRAINDICATED PRODUCT ADMINISTERED 22 0.0007
770 EAR PAIN 14 0.0007
771 GASTROENTERITIS VIRAL 13 0.0007
772 BLOOD PRESSURE SYSTOLIC INCREASED 14 0.0007
773 HAEMORRHAGE 75 0.0007
774 MOBILITY DECREASED 51 0.0007
775 HYPERTENSION 150 0.0007
776 VOMITING 331 0.0007
777 SINUSITIS 72 0.0007
778 INFUSION RELATED REACTION 46 0.0007
779 ULCER 11 0.0007
780 PHOTOPHOBIA 13 0.0007
781 FEEDING DISORDER 14 0.0007
782 SKIN DISORDER 23 0.0007
783 HEPATIC ENZYME INCREASED 47 0.0007
784 ORTHOSTATIC HYPOTENSION 12 0.0007
785 BLINDNESS 28 0.0007
786 APPLICATION SITE ERYTHEMA 18 0.0007
787 FEELING COLD 19 0.0007
788 ALOPECIA 134 0.0007
789 DIABETES MELLITUS INADEQUATE CONTROL 12 0.0007
790 OVERDOSE 146 0.0007
791 GLAUCOMA 13 0.0007
792 BURNING SENSATION 47 0.0007
793 DYSPHONIA 39 0.0007
794 HAEMORRHOIDS 13 0.0007
795 HYPERSENSITIVITY 123 0.0007
796 LOCALISED INFECTION 16 0.0007
797 COVID-19 116 0.0007
798 CORONARY ARTERY DISEASE 20 0.0007
799 CARDIAC FAILURE CONGESTIVE 53 0.0007
800 SYNCOPE 66 0.0007
801 SINUS DISORDER 13 0.0007
802 PHARYNGEAL OEDEMA 10 0.0006
803 HEMIPARESIS 11 0.0006
804 WHITE BLOOD CELL COUNT DECREASED 70 0.0006
805 DYSKINESIA 26 0.0006
806 INTENTIONAL PRODUCT MISUSE 56 0.0006
807 EYE PAIN 36 0.0006
808 OSTEOARTHRITIS 27 0.0006
809 DECREASED APPETITE 147 0.0006
810 LIVER DISORDER 28 0.0006
811 SKIN DISCOLOURATION 29 0.0006
812 VIRAL INFECTION 21 0.0006
813 SCIATICA 10 0.0006
814 TREMOR 104 0.0006
815 HYPOPHAGIA 16 0.0006
816 HERNIA 12 0.0006
817 DYSPNOEA 346 0.0006
818 IMPAIRED HEALING 20 0.0006
819 URTICARIA 102 0.0006
820 PRODUCT USE ISSUE 114 0.0006
821 RESTLESS LEGS SYNDROME 11 0.0006
822 HALLUCINATION 45 0.0006
823 MOVEMENT DISORDER 19 0.0006
824 DRUG ADMINISTRATION ERROR 18 0.0006
825 UPPER RESPIRATORY TRACT INFECTION 27 0.0006
826 DYSPNOEA EXERTIONAL 22 0.0006
827 BLOOD URINE PRESENT 11 0.0006
828 SLEEP APNOEA SYNDROME 11 0.0006
829 CHROMATURIA 13 0.0006
830 CATARACT 34 0.0006
831 PRESCRIBED OVERDOSE 11 0.0006
832 HYPOTHYROIDISM 18 0.0006
833 STOMATITIS 34 0.0006
834 GALLBLADDER DISORDER 10 0.0006
835 DYSARTHRIA 21 0.0006
836 ABNORMAL BEHAVIOUR 22 0.0006
837 PRURITUS GENERALISED 12 0.0006
838 ECZEMA 29 0.0006
839 ABDOMINAL PAIN LOWER 14 0.0006
840 IRRITABILITY 33 0.0005
841 FULL BLOOD COUNT DECREASED 11 0.0005
842 NEPHROLITHIASIS 25 0.0005
843 THROAT IRRITATION 24 0.0005
844 HYPOAESTHESIA 80 0.0005
845 PALPITATIONS 62 0.0005
846 HAEMATOCHEZIA 29 0.0005
847 HEART RATE INCREASED 52 0.0005
848 PRODUCTIVE COUGH 25 0.0005
849 PRURITUS 201 0.0005
850 LIMB DISCOMFORT 16 0.0005
851 IMPAIRED WORK ABILITY 11 0.0005
852 IRRITABLE BOWEL SYNDROME 11 0.0005
853 LIVER FUNCTION TEST INCREASED 11 0.0005
854 BONE PAIN 30 0.0005
855 SOMNOLENCE 103 0.0005
856 NECK PAIN 28 0.0005
857 PAIN 307 0.0005
858 COUGH 139 0.0005
859 JOINT STIFFNESS 13 0.0005
860 BACK PAIN 115 0.0005
861 MYALGIA 84 0.0005
862 NAUSEA 390 0.0005
863 DEPRESSION 112 0.0005
864 SWELLING 46 0.0005
865 ABASIA 12 0.0005
866 WEIGHT DECREASED 135 0.0005
867 ILL-DEFINED DISORDER 29 0.0005
868 TYPE 2 DIABETES MELLITUS 16 0.0005
869 URINARY INCONTINENCE 14 0.0005
870 INCORRECT DOSE ADMINISTERED 107 0.0005
871 INTENTIONAL PRODUCT USE ISSUE 41 0.0005
872 CONTUSION 45 0.0005
873 OSTEOPOROSIS 19 0.0005
874 AGGRESSION 23 0.0005
875 DISCOMFORT 28 0.0005
876 BLOOD PRESSURE FLUCTUATION 11 0.0005
877 INTERVERTEBRAL DISC PROTRUSION 10 0.0005
878 EYE SWELLING 17 0.0005
879 CEREBROVASCULAR ACCIDENT 77 0.0005
880 MENTAL IMPAIRMENT 11 0.0005
881 BLOOD PRESSURE ABNORMAL 9 0.0005
882 HERPES ZOSTER 26 0.0005
883 PRESYNCOPE 11 0.0005
884 THROMBOSIS 36 0.0004
885 LOSS OF CONSCIOUSNESS 57 0.0004
886 VISION BLURRED 61 0.0004
887 FATIGUE 342 0.0004
888 SLEEP DISORDER 31 0.0004
889 MUSCULOSKELETAL PAIN 23 0.0004
890 BRONCHITIS 32 0.0004
891 ARTHRITIS 34 0.0004
892 MALAISE 189 0.0004
893 EPILEPSY 13 0.0004
894 GAIT DISTURBANCE 81 0.0004
895 OCULAR HYPERAEMIA 20 0.0004
896 ASTHENIA 158 0.0004
897 PARAESTHESIA 66 0.0004
898 EAR INFECTION 11 0.0004
899 DYSSTASIA 12 0.0004
900 MYOCARDIAL INFARCTION 71 0.0004
901 DIZZINESS 203 0.0004
902 MUSCULOSKELETAL STIFFNESS 35 0.0004
903 PROCEDURAL PAIN 11 0.0004
904 DEMENTIA 11 0.0004
905 INCORRECT ROUTE OF DRUG ADMINISTRATION 14 0.0004
906 HYPERHIDROSIS 50 0.0004
907 HOT FLUSH 29 0.0004
908 RED BLOOD CELL COUNT DECREASED 11 0.0004
909 POLLAKIURIA 16 0.0004
910 BONE DENSITY DECREASED 12 0.0004
911 GASTROINTESTINAL DISORDER 34 0.0004
912 ARTHRALGIA 153 0.0004
913 BLOOD PRESSURE INCREASED 56 0.0004
914 TREATMENT NONCOMPLIANCE 20 0.0004
915 EYE IRRITATION 21 0.0004
916 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 19 0.0004
917 MYELOSUPPRESSION 13 0.0004
918 DRY EYE 18 0.0004
919 FEELING HOT 22 0.0004
920 EMOTIONAL DISORDER 11 0.0004
921 TRANSIENT ISCHAEMIC ATTACK 12 0.0004
922 VISUAL IMPAIRMENT 44 0.0004
923 DIABETES MELLITUS 27 0.0004
924 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 17 0.0004
925 INFLUENZA LIKE ILLNESS 29 0.0004
926 ANGINA PECTORIS 10 0.0003
927 CONSTIPATION 76 0.0003
928 HEAD INJURY 11 0.0003
929 MENTAL DISORDER 15 0.0003
930 SPEECH DISORDER 18 0.0003
931 AMNESIA 22 0.0003
932 DEATH 290 0.0003
933 OROPHARYNGEAL PAIN 31 0.0003
934 EYE DISORDER 11 0.0003
935 RESTLESSNESS 12 0.0003
936 DRY MOUTH 26 0.0003
937 FALL 106 0.0003
938 DISTURBANCE IN ATTENTION 17 0.0003
939 THERAPEUTIC PRODUCT EFFECT DECREASED 14 0.0003
940 CHEST DISCOMFORT 32 0.0003
941 PAIN IN EXTREMITY 92 0.0003
942 ASTHMA 35 0.0003
943 JOINT SWELLING 37 0.0003
944 OSTEONECROSIS 10 0.0003
945 ABDOMINAL PAIN UPPER 62 0.0003
946 HOSPITALISATION 46 0.0003
947 GAIT INABILITY 10 0.0003
948 RHINORRHOEA 19 0.0003
949 MALIGNANT NEOPLASM PROGRESSION 30 0.0003
950 MEMORY IMPAIRMENT 40 0.0003
951 ARTHROPATHY 16 0.0003
952 NERVOUSNESS 15 0.0003
953 DEPRESSED MOOD 15 0.0003
954 INSOMNIA 75 0.0003
955 ILLNESS 29 0.0003
956 HEADACHE 176 0.0003
957 DRUG INTOLERANCE 26 0.0003
958 CARDIAC DISORDER 25 0.0003
959 MUSCLE SPASMS 49 0.0003
960 THERAPEUTIC RESPONSE DECREASED 16 0.0003
961 PERIPHERAL SWELLING 40 0.0003
962 BLOOD CHOLESTEROL INCREASED 12 0.0003
963 ABDOMINAL DISCOMFORT 43 0.0003
964 PLASMA CELL MYELOMA 10 0.0003
965 ADVERSE DRUG REACTION 23 0.0003
966 VAGINAL HAEMORRHAGE 11 0.0003
967 THERAPY CESSATION 12 0.0002
968 INFLUENZA 26 0.0002
969 PSORIASIS 30 0.0002
970 ABORTION SPONTANEOUS 9 0.0002
971 WEIGHT INCREASED 50 0.0002
972 SURGERY 13 0.0002
973 NASAL CONGESTION 13 0.0002
974 FLUID RETENTION 11 0.0002
975 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 15 0.0002
976 FEELING ABNORMAL 45 0.0002
977 DRY SKIN 23 0.0002
978 FLUSHING 17 0.0002
979 DRUG EFFECT DECREASED 9 0.0002
980 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 30 0.0002
981 BLOOD GLUCOSE INCREASED 31 0.0002
982 ADVERSE EVENT 15 0.0002
983 ACNE 12 0.0002
984 THERAPY INTERRUPTED 11 0.0002
985 PRODUCT DOSE OMISSION ISSUE 42 0.0001
986 SKIN BURNING SENSATION 10 0.0001
987 RHEUMATOID ARTHRITIS 15 0.0001
988 NASOPHARYNGITIS 24 0.0001
989 DEVICE MALFUNCTION 9 0.0001
990 MIGRAINE 12 0.0001
991 NO ADVERSE EVENT 22 0.0001
992 DYSGEUSIA 9 0.0001
993 PRODUCT QUALITY ISSUE 10 0.0001
994 INJECTION SITE PAIN 17 0.0001